Saphnelo Now Available in Malaysia as an Add-On Treatment for Adult Patients with Moderate to Severe, Active Autoantibody-Positive Systemic Lupus Erythematosus (SLE)
AstraZeneca’s Saphnelo (anifrolumab) has now become available as add-on treatment for adult patients in Malaysia with moderate to severe, active...
